AI assistant
SYNAPTICS Inc — Director's Dealing 2015
Feb 4, 2015
31479_dirs_2015-02-03_31febb02-ac6c-4ce5-865d-d1ea17391596.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SYNAPTICS INC (SYNA)
CIK: 0000817720
Period of Report: 2015-01-30
Reporting Person: BAYLESS KATHLEEN A (SVP, CFO, & Treasurer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-02-02 | Common Stock | M | 1625 | $37.20 | Acquired | 19582 | Direct |
| 2015-02-02 | Common Stock | M | 2065 | $39.80 | Acquired | 21647 | Direct |
| 2015-02-02 | Common Stock | M | 1310 | $61.40 | Acquired | 22957 | Direct |
| 2015-02-02 | Common Stock | S | 5000 | $75.0748 | Disposed | 17957 | Direct |
| 2015-02-02 | Common Stock | F | 312 | $77.88 | Disposed | 17645 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-01-30 | Employee Stock Option (Right to Buy) | $76.81 | A | 3000 | Acquired | 2022-01-30 | Common Stock (3000) | Direct |
| 2015-02-02 | Employee Stock Option (Right to Buy) | $37.20 | M | 1625 | Disposed | 2019-01-30 | Common Stock (1625) | Direct |
| 2015-02-02 | Employee Stock Option (Right to Buy) | $39.80 | M | 2065 | Disposed | 2020-08-05 | Common Stock (2065) | Direct |
| 2015-02-02 | Employee Stock Option (Right to Buy) | $61.40 | M | 1310 | Disposed | 2021-04-28 | Common Stock (1310) | Direct |
Footnotes
F1: Includes 402 shares acquired under the Issuer's employee stock purchase plan in November 2014, but not previously reported.
F2: The amount of securities beneficially owned by the reporting person on the reporting person's previous Form 4 erroneously included an additional 4,300 shares.
F3: The shares were sold pursuant to a 10b5-1 Sales Plan dated August 19, 2014.
F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.01 to $75.275,
inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
F5: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of deferred stock units.
F6: 1/12th of the total number of shares subject to the option shall vest and become exercisable each quarter following the January 30, 2015 date of grant, until fully vested on January 30, 2018.
F7: 1/48th of the total number of shares subject to the option vested or shall vest and became or shall become exercisable on the 30th day of each month following the January 30, 2012 date of grant, until fully vested on January 30, 2016.
F8: 1/36th of the total number of shares subject to the option vested or shall vest and became or shall become exercisable on the 5th day of each month following the August 5, 2013 date of grant, until fully vested on August 5, 2016.
F9: 1/12th of the total number of shares subject to the option vested or shall vest and became or shall become exercisable each quarter following the April 28, 2014 date of grant, until fully vested on April 28, 2017.